simendan has been researched along with Alloxan Diabetes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Alzoubi, KH; Baydoun, S; Khabour, OF; Rababa'h, AM | 1 |
| Abdelrahman, AM; Al Salam, S; Al Suleimani, Y; Ali, BH; Ashique, M; Manoj, P | 1 |
| Alkan, M; Arslan, M; Bilge, M; Çelik, A; Erdem, Ö; Kavutçu, M; Kip, G; Kiraz, HA; Özer, A; Şıvgın, V | 1 |
| Alkan, M; Arslan, M; Comu, FM; Kip, G; Kiraz, HA; Ozer, A; Sivgin, V | 1 |
| Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Hassan, Q; Najmi, AK; Pillai, KK | 1 |
| Akhtar, MS; Dhyani, N; Hassan, MQ; Ismail, MV; Najmi, AK; Pillai, KK | 1 |
| Kaheinen, P; Lakkisto, J; Lakkisto, P; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, E; Storvik, M; Tikkanen, I; Vahtola, E | 1 |
7 other study(ies) available for simendan and Alloxan Diabetes
| Article | Year |
|---|---|
Levosimendan Prevents Memory Impairment Induced by Diabetes in Rats: Role of Oxidative Stress.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Maze Learning; Memory; Memory Disorders; Oxidative Stress; Phosphodiesterase 3 Inhibitors; Rats; Rats, Wistar; Simendan | 2019 |
Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cardiotonic Agents; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Kidney; Male; Oxidative Stress; Polyuria; Rats; Rats, Sprague-Dawley; Simendan | 2020 |
The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Hydrazones; Lung Injury; Male; Myocardial Reperfusion Injury; Pyridazines; Random Allocation; Rats, Wistar; Simendan; Vasodilator Agents | 2015 |
Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury.
Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Erythrocyte Deformability; Hydrazones; Male; Myocardial Reperfusion Injury; Pyridazines; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Simendan; Streptozocin | 2015 |
Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Topics: Animals; Apoptosis; C-Reactive Protein; Cardiotonic Agents; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glutathione Peroxidase; Hydrazones; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Oxidative Stress; Pyridazines; Ramipril; Rats; Rats, Wistar; Simendan; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway.
Topics: Animals; Body Weight; Cardiomyopathies; Cardiotonic Agents; Diabetes Mellitus, Experimental; Heart; Hemodynamics; Hydrazones; Male; Natriuretic Peptide, Brain; Nitric Oxide; Pyridazines; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Calcium Exchanger; Streptozocin; Transforming Growth Factor beta; Troponin I | 2016 |
Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
Topics: Animals; Diabetes Mellitus, Experimental; Down-Regulation; Gene Expression Profiling; Heart; Heart Failure; Hydrazones; Immunohistochemistry; Microarray Analysis; Myocardial Infarction; Myocardium; Pyridazines; Rats; Rats, Wistar; Renin-Angiotensin System; Simendan; Transcriptome; Up-Regulation; Ventricular Remodeling | 2011 |